Roche Holding AG (RHHVF)
289.09
-5.79
(-1.96%)
USD |
OTCM |
Nov 14, 16:00
Roche Price: 289.09 for Nov. 14, 2024
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 14, 2024 | 290.90 | 297.51 | 289.09 | 289.09 | 39768.00 |
| Nov 13, 2024 | 297.00 | 299.36 | 294.88 | 294.88 | 14813.00 |
| Nov 12, 2024 | 296.87 | 300.00 | 294.78 | 299.36 | 13159.00 |
| Nov 11, 2024 | 300.00 | 304.08 | 298.90 | 300.09 | 7052.00 |
| Nov 08, 2024 | 300.58 | 304.99 | 296.24 | 299.84 | 371.00 |
| Nov 07, 2024 | 305.44 | 306.91 | 302.46 | 302.82 | 7344.00 |
| Nov 06, 2024 | 306.19 | 306.21 | 302.00 | 302.20 | 458.00 |
| Nov 05, 2024 | 315.98 | 315.98 | 308.29 | 308.29 | 228.00 |
| Nov 04, 2024 | 317.27 | 317.27 | 312.00 | 312.50 | 2992.00 |
| Nov 01, 2024 | 315.51 | 315.51 | 311.82 | 312.59 | 151.00 |
| Oct 31, 2024 | 309.21 | 311.53 | 308.09 | 308.09 | 7382.00 |
| Oct 30, 2024 | 310.90 | 313.13 | 310.90 | 312.30 | 303.00 |
| Oct 29, 2024 | 316.82 | 319.92 | 315.64 | 315.64 | 486.00 |
| Oct 28, 2024 | 320.44 | 324.09 | 317.87 | 318.01 | 347.00 |
| Oct 25, 2024 | 320.99 | 324.50 | 320.85 | 320.85 | 630.00 |
| Oct 24, 2024 | 322.11 | 323.68 | 320.07 | 321.00 | 64.00 |
| Oct 23, 2024 | 321.47 | 321.47 | 316.80 | 321.00 | 677.00 |
| Oct 22, 2024 | 311.00 | 314.40 | 311.00 | 313.74 | 24299.00 |
| Oct 21, 2024 | 317.57 | 317.57 | 311.87 | 311.87 | 804.00 |
| Oct 18, 2024 | 313.63 | 317.33 | 312.62 | 312.62 | 1488.00 |
| Oct 17, 2024 | 310.52 | 314.41 | 310.39 | 312.58 | 1060.00 |
| Oct 16, 2024 | 312.99 | 315.17 | 307.61 | 307.61 | 230.00 |
| Oct 15, 2024 | 312.25 | 317.94 | 310.40 | 315.00 | 391.00 |
| Oct 14, 2024 | 311.00 | 314.92 | 310.11 | 312.50 | 449.00 |
| Oct 11, 2024 | 312.00 | 313.78 | 309.21 | 311.56 | 700.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
233.27
Minimum
May 06 2024
425.14
Maximum
Apr 11 2022
327.75
Average
327.14
Median
Price Benchmarks
| AC Immune SA | 3.55 |
| CRISPR Therapeutics AG | 46.85 |
| Addex Therapeutics Ltd | 8.20 |
| NLS Pharmaceutics Ltd | 3.34 |
| Molecular Partners AG | 5.25 |
Price Related Metrics
| PE Ratio | 19.58 |
| PS Ratio | 3.431 |
| Price to Book Value | 7.154 |
| Price to Free Cash Flow | 18.32 |
| Earnings Yield | 5.11% |
| Market Cap | 230.34B |
| Operating PE Ratio | 14.17 |
| Normalized PE Ratio | 18.87 |